Global Cardiology Academy - Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

How Artificial Sweeteners Could Be Linked to Heart Disease
How Artificial Sweeteners Could Be Linked to Heart Disease
Heart Matters
How Artificial Sweeteners Could Be Linked to Heart Disease
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Wilson Tang, MD
Deep Learner: Building AI to Improve Cardiovascular Care
Deep Learner: Building AI to Improve Cardiovascular Care
Medical Industry Feature
Deep Learner: Building AI to Improve Cardiovascular Care
- Pierre Elias, MD
Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Medical Industry Feature
Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
- Christopher Petit, MD
Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
MinuteCE®
Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
1.75 program credits
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
MinuteCE®
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
1.75 program credits
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits
Case Time! VTE Prophylaxis Post Hip Replacement
Case Time! VTE Prophylaxis Post Hip Replacement
MinuteCE®
Case Time! VTE Prophylaxis Post Hip Replacement
1.75 program credits
- Victor F. Tapson, MD
1.75 program credits
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
MinuteCE®
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
1.75 program credits
- Scott Kaatz, DO, MSc, FACP, SFHM
1.75 program credits
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
MinuteCE®
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
1.75 program credits
- Deborah Siegal, MD, MSc, FRCPC
1.75 program credits

Programs

Right from the Onset: DVT Diagnosis, Management
Right from the Onset: DVT Diagnosis, Management
MinuteCE®
Right from the Onset: DVT Diagnosis, Management
1.75 program credits
- Bruce L. Davidson, MD, MPH
1.75 program credits
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
MinuteCE®
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
1.75 program credits
- Alfonso J. Tafur, MD, MS, MBA, RPVI
1.75 program credits
Right from the Onset: PE Diagnosis, Management
Right from the Onset: PE Diagnosis, Management
MinuteCE®
Right from the Onset: PE Diagnosis, Management
1.75 program credits
- Bruce L. Davidson, MD, MPH
1.75 program credits
MinuteCE®
Primary Prevention, Initial Treatment & Management of VTE, Secondary VTE Prevention Strategies
1.75 credits 12 episodes
- Bruce L. Davidson, MD, MPH
- Scott Kaatz, DO, MSc, FACP, SFHM
- Deborah Siegal, MD, MSc, FRCPC
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
- Alfonso J. Tafur, MD, MS, MBA, RPVI
- Victor F. Tapson, MD
1.75 credits 12 episodes
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
MinuteCE®
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
1.75 program credits
- Deborah Siegal, MD, MSc, FRCPC
1.75 program credits
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
MinuteCE®
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
1.75 program credits
- Scott Kaatz, DO, MSc, FACP, SFHM
1.75 program credits
Active Aging: Preventing Heart Failure in Older Women with Exercise
Active Aging: Preventing Heart Failure in Older Women with Exercise
Heart Matters
Active Aging: Preventing Heart Failure in Older Women with Exercise
- Javed Butler, MD, MBA, MPH
- Michael J. LaMonte, PhD, MPH
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
MinuteCE®
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
1.00 program credit
- Manesh R. Patel, MD
1.00 program credit

Clinical Practice

What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
MinuteCE®
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
1.75 program credits
- Alfonso J. Tafur, MD, MS, MBA, RPVI
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits
Latest Guidance on Anticoagulation in AF Patient Populations with Comorbidities
Latest Guidance on Anticoagulation in AF Patient Populations with Comorbidities
MinuteCE®
Latest Guidance on Anticoagulation in AF Patient Populations with Comorbidities
1.00 program credit
- Manesh R. Patel, MD
1.00 program credit
What Are the Latest Updates on the Clinical and Economic Impact of AF?
What Are the Latest Updates on the Clinical and Economic Impact of AF?
MinuteCE®
What Are the Latest Updates on the Clinical and Economic Impact of AF?
1.00 program credit
- Sean Pokorney, MD
1.00 program credit
Anticoagulation Management of AF: What Has Changed?
Anticoagulation Management of AF: What Has Changed?
MinuteCE®
Anticoagulation Management of AF: What Has Changed?
1.00 program credit
- Sean Pokorney, MD
1.00 program credit
AF Screening, Risk Factors, and Diagnosis: What’s New?
AF Screening, Risk Factors, and Diagnosis: What’s New?
MinuteCE®
AF Screening, Risk Factors, and Diagnosis: What’s New?
1.00 program credit
- Mina K. Chung, MD
1.00 program credit
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Clinician's Roundtable
Improving CKD Patient Outcomes with SGLT2 Inhibitors
- Gates B. Colbert, MD, FASN
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Heart Matters
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
The Path Forward: What’s On the Horizon?
The Path Forward: What’s On the Horizon?
MinuteCE®
The Path Forward: What’s On the Horizon?
1.50 program credits
- Manesh R. Patel, MD
1.50 program credits

CME

Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
MinuteCE®
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
1.75 program credits
- Bruce L. Davidson, MD, MPH
- Victor F. Tapson, MD
1.75 program credits
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
MinuteCE®
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
1.00 program credit
- Manesh R. Patel, MD
1.00 program credit
Latest Guidance on Anticoagulation in Special AF Patient Populations
Latest Guidance on Anticoagulation in Special AF Patient Populations
MinuteCE®
Latest Guidance on Anticoagulation in Special AF Patient Populations
1.00 program credit
- Sean Pokorney, MD
1.00 program credit
While Antiplatelets Are Good…They Aren’t for Everyone
While Antiplatelets Are Good…They Aren’t for Everyone
MinuteCE®
While Antiplatelets Are Good…They Aren’t for Everyone
1.50 program credits
- Valeria Caso, MD, PhD
1.50 program credits
What Anticoagulation Options Are Available To Optimize Care in the Management of Elderly Patients With Atrial Fibrillation?
What Anticoagulation Options Are Available To Optimize Care in the Management of Elderly Patients With Atrial Fibrillation?
MinuteCE®
What Anticoagulation Options Are Available To Optimize Care in the Management of Elderly Patients With Atrial Fibrillation?
0.75 program credits
- Manesh R. Patel, MD
- Sean Pokorney, MD
0.75 program credits
The Case of Arthur Frank: How Do We Manage Elderly Patients with Atrial Fibrillation?
The Case of Arthur Frank: How Do We Manage Elderly Patients with Atrial Fibrillation?
MinuteCE®
The Case of Arthur Frank: How Do We Manage Elderly Patients with Atrial Fibrillation?
0.75 program credits
- Manesh R. Patel, MD
- Sean Pokorney, MD
0.75 program credits
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Elderly Patient With Atrial Fibrillation
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Elderly Patient With Atrial Fibrillation
MinuteCE®
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Elderly Patient With Atrial Fibrillation
0.75 program credits
- Manesh R. Patel, MD
- Sean Pokorney, MD
0.75 program credits
Comprehensive Anticoagulation Management for Atrial Fibrillation
Comprehensive Anticoagulation Management for Atrial Fibrillation
MinuteCE®
Comprehensive Anticoagulation Management for Atrial Fibrillation
1.25 program credits
- Manesh R. Patel, MD
- Steve Deitelzweig, MD, MMM, SFHM, FACP, FACC
1.25 program credits